CHSYF (China Medical System Holdings) Shares Outstanding (EOP): 2,440 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHSYF China Medical System Holdings Ltd CHSYF
87 GF Score
Price $1.57
GF Value $1.30
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is China Medical System Holdings Shares Outstanding (EOP)?

China Medical System Holdings CHSYF +0.11% 87 Shares Outstanding (EOP) is 2,440 Mil as of Dec. 2025. GuruFocus rates CHSYF with a GF Score™ of 87/100 and a GF Value™ of $1.30 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. China Medical System Holdings's shares outstanding for the quarter that ended in Dec. 2025 was 2,440 Mil.

China Medical System Holdings's quarterly shares outstanding stayed the same from Jun. 2025 (2,440 Mil) to Dec. 2025 (2,440 Mil).

China Medical System Holdings's annual shares outstanding stayed the same from Dec. 2024 (2,440 Mil) to Dec. 2025 (2,440 Mil).


China Medical System Holdings  (OTCPK:CHSYF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


China Medical System Holdings Shares Outstanding (EOP) Related Terms


China Medical System Holdings Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for China Medical System Holdings's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Medical System Holdings Shares Outstanding (EOP) Chart

China Medical System Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,457.44 2,451.99 2,451.99 2,439.53 2,439.53

China Medical System Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,451.99 2,416.53 2,439.53 2,439.53 2,439.53

CHSYF vs ZTS: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's Shares Outstanding (EOP) falls into.


CHSYF
87GF Score
China Medical System Holdings Ltd CHSYF
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Medical System Holdings Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 2,440 Mil mean?
China Medical System Holdings (CHSYF) has a Shares Outstanding (EOP) of 2,440 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on China Medical System Holdings and its competitors.
Is China Medical System Holdings' Shares Outstanding (EOP) too high?
China Medical System Holdings' current Shares Outstanding (EOP) is 2,440 Mil. Overall, China Medical System Holdings has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' Shares Outstanding (EOP) compare to ZTS?
China Medical System Holdings' Shares Outstanding (EOP) of 2,440 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on China Medical System Holdings and its competitors. China Medical System Holdings's current Shares Outstanding (EOP) is 2,440 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.30, compared to a current price of $1.57 — trading 20.8% above its estimated fair value. The current Shares Outstanding (EOP) is 2,440 Mil. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current Shares Outstanding (EOP) is 2,440 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Medical System Holdings (CHSYF) Overvalued in 2026?

Based on GuruFocus' analysis, China Medical System Holdings stock appears to be overvalued. The current stock price of $1.57 is trading 20.8% above its estimated GF Value™ of $1.30. GuruFocus considers China Medical System Holdings to be Modestly Overvalued.

Key valuation signals for CHSYF:

  • Shares Outstanding (EOP): 2,440 Mil
  • GF Value™: $1.30 vs. price of $1.57 (20.8% above fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Medical System Holdings Business Description

Address 510 King’s Road, Unit 2106, 21st Floor, Island Place Tower, North Point, Hong Kong, HKG
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score

Get the complete analysis for CHSYF

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.57
Price
$1.30
GF Value